Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D. Wiviott, Marc S. Sabatine, Ofri Mosenzon et al.|New England Journal of Medicine|2018Cited by 6.3k
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trialTze‐Fan Chao, Robert P. Giugliano, Shih‐Ann Chen et al.|European Heart Journal|2018Cited by 106